EDGAR Filing Documents for 0000950170-24-030088

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0000950170-24-030088

Filing Date

2024-03-12

Accepted

2024-03-12 17:04:07

Documents

Effectiveness Date

2024-03-12

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	lbph_s-8_march_2024.htm	S-8	104168
2	EX-5.1	lbph-ex5_1.htm	EX-5.1	18246
3	EX-23.1	lbph-ex23_1.htm	EX-23.1	4172
4	EX-FILING FEES	lbph-exfiling_fees.htm	EX-FILING FEES	46250
5	GRAPHIC	img207609832_0.jpg	GRAPHIC	29364
6	GRAPHIC	img207609832_1.jpg	GRAPHIC	29364
	Complete submission text file	0000950170-24-030088.txt		255024

Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037

Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775

Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277862 | Film No.: 24743169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)